These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2548009)

  • 1. Poliovirus-associated protein kinase: destabilization of the virus capsid and stimulation of the phosphorylation reaction by Zn2+.
    Ratka M; Lackmann M; Ueckermann C; Karlins U; Koch G
    J Virol; 1989 Sep; 63(9):3954-60. PubMed ID: 2548009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of poliovirus associated protein kinase.
    Lackmann M; Ueckermann C; Engelmann K; Koch G
    Arch Virol; 1987; 95(1-2):1-16. PubMed ID: 3036040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4.
    Hindiyeh M; Li QH; Basavappa R; Hogle JM; Chow M
    J Virol; 1999 Nov; 73(11):9072-9. PubMed ID: 10516013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase activity in purified poliovirus particles and empty viral capsid preparations.
    Schärli CE; Koch G
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():129-39. PubMed ID: 6319565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage sites within the poliovirus capsid protein precursors.
    Larsen GR; Anderson CW; Dorner AJ; Semler BL; Wimmer E
    J Virol; 1982 Jan; 41(1):340-4. PubMed ID: 6283126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalysis of poliovirus VP0 maturation cleavage is not mediated by serine 10 of VP2.
    Harber JJ; Bradley J; Anderson CW; Wimmer E
    J Virol; 1991 Jan; 65(1):326-34. PubMed ID: 1845893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions.
    Ansardi DC; Morrow CD
    J Virol; 1995 Mar; 69(3):1540-7. PubMed ID: 7853487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature-sensitive poliovirus mutant fails to cleave VP0 and accumulates provirions.
    Compton SR; Nelsen B; Kirkegaard K
    J Virol; 1990 Sep; 64(9):4067-75. PubMed ID: 2166805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1992 Jul; 66(7):4556-63. PubMed ID: 1318418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Poliovirus Capsid Proteins with the Cellular Autophagy Pathway.
    Zimina A; Viktorova EG; Moghimi S; Nchoutmboube J; Belov GA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amino-terminal nine amino acid sequence of poliovirus capsid VP4 protein is sufficient to confer N-myristoylation and targeting to detergent-insoluble membranes.
    Martín-Belmonte F; López-Guerrero JA; Carrasco L; Alonso MA
    Biochemistry; 2000 Feb; 39(5):1083-90. PubMed ID: 10653654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans.
    Porter DC; Ansardi DC; Morrow CD
    J Virol; 1995 Mar; 69(3):1548-55. PubMed ID: 7853488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.
    Ansardi DC; Morrow CD
    J Virol; 1993 Dec; 67(12):7284-97. PubMed ID: 8230452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The poliovirus empty capsid specifically recognizes the poliovirus receptor and undergoes some, but not all, of the transitions associated with cell entry.
    Basavappa R; Gómez-Yafal A; Hogle JM
    J Virol; 1998 Sep; 72(9):7551-6. PubMed ID: 9696852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action and capsid-stabilizing properties of VHHs with an in vitro antipolioviral activity.
    Schotte L; Strauss M; Thys B; Halewyck H; Filman DJ; Bostina M; Hogle JM; Rombaut B
    J Virol; 2014 Apr; 88(8):4403-13. PubMed ID: 24501405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating.
    Couderc T; Delpeyroux F; Le Blay H; Blondel B
    J Virol; 1996 Jan; 70(1):305-12. PubMed ID: 8523541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus.
    Curry S; Fry E; Blakemore W; Abu-Ghazaleh R; Jackson T; King A; Lea S; Newman J; Stuart D
    J Virol; 1997 Dec; 71(12):9743-52. PubMed ID: 9371640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.
    Marc D; Masson G; Girard M; van der Werf S
    J Virol; 1990 Sep; 64(9):4099-107. PubMed ID: 2166807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions.
    Mosser AG; Sgro JY; Rueckert RR
    J Virol; 1994 Dec; 68(12):8193-201. PubMed ID: 7966611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry.
    Strauss M; Filman DJ; Belnap DM; Cheng N; Noel RT; Hogle JM
    J Virol; 2015 Apr; 89(8):4143-57. PubMed ID: 25631086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.